Lipid Signaling, Therapeutics and Controlled-Release

Dear Colleagues,

The International Conference on the Bioscience of Lipids (ICBL) is the foremost academic forum in the world today for the presentation and discussion of the latest developments and discoveries regarding the chemical, biological, nutritional, and clinical aspects of lipids. Founded by Nobel Laureates Sune Bergström, Christian de Duve, and Konrad Bloch, the spirit of the ICBL is to provide a friendly and intellectually stimulating environment where the latest discoveries and ideas on lipid science can be freely discussed and young and established researchers alike can gather to build new collaborations and long-lasting friendships.

As ICBL (International Conference on the Bioscience of Lipids) 2024 academic committee members, Dr Ma and Dr Sun have jointly decided to organize this Special Issue to collect the most important and up-to-date findings presented at the conference.

This year, the conference will comprise the following six sessions. These themes cover a wide spectrum of biomedical sciences.

1. Advances of Lipidomics;
2. From Lipid to Biomarker;
3. Disorders in the Lipid Metabolism: Mechanism and Solution;
4. Lipid Diversity and Evolution;
5. Lipids in Clinical and Translational Research;
6. Lipids in Immunology.

Undoubtedly, studies relating to lipid signals in physiology and pathology are increasing as targeting these signals might benefit the health industry. This targeting strategy could also feature lipids themselves: for instance, liposome-based nanoparticle (LNP) controlled-release drug delivery technologies have been a hot and fast-developing topic in current biotechnology.

Prof. Dr. Wen-Lung Ma
Dr. Hung-Yu Sun
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Metabolites is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.